Medication info
Colostatin 2.5 mg (Rosuvastatin Calcium)

Colostatin 2.5 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›2.6mg / 1 tablet
Manufacturer / importer
Shinpoong Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202301094 · Approved 2023.03.31 · Insurance code 648508240

Summary

Main use
Improvement of primary hypercholesterolemia and combined hyperlipidemia
Who uses it
Adults
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and continue it throughout the treatment period. This drug may be taken at any time of day, regardless of meals. The initial dose is 2.5 or 5 milligrams once daily; for patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased up to a maximum of 20 milligrams once daily. Elderly patients: No dose adjustment is necessary. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this drug to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 2.5 or 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Ingredients

Manufacturer
Shinpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and combined hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
View approved original text

This medication is used for the treatment of primary hypercholesterolemia and mixed hyperlipidemia. Specifically, it is applicable to patients with type IIa and type IIb hyperlipidemia, including heterozygous familial hypercholesterolemia. It is used to supplement dietary therapy when not controlled by diet and exercise. This medication helps lower blood cholesterol levels, reducing the risk of cardiovascular disease. Regular use improves blood lipid levels and supports the maintenance of patient health. Therefore, it is effectively used in the treatment of hyperlipidemia.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and continue it throughout the treatment period. This drug may be taken at any time of day, regardless of meals. The initial dose is 2.5 or 5 milligrams once daily; for patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased up to a maximum of 20 milligrams once daily. Elderly patients: No dose adjustment is necessary. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this drug to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 2.5 or 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Precautions

This medication should not be administered to certain patients. For example, individuals who are allergic to any of its components, those with severely impaired liver function, or those with muscle diseases should avoid it. Additionally, patients with significantly reduced kidney function and women who are pregnant or breastfeeding should not take this medication. This medication contains lactose, making it unsuitable for patients with genetic metabolic disorders such as lactose intolerance. While using this medication, liver function and muscle condition should be carefully monitored. Individuals with a history of liver disease or who consume alcohol excessively should have regular liver enzyme tests. If symptoms of muscle pain or weakness occur, immediate notification to medical personnel is essential, and discontinuation of the medication may be necessary. This medication can interact with other drugs, so it is crucial to inform your healthcare provider of any other medications being taken. In particular, the risk of muscle-related adverse reactions may increase when used with certain antibiotics, antifungals, immunosuppressants, or fibrates. Women of childbearing potential are advised to use proper contraception while taking this medication and to discontinue use immediately if pregnancy occurs. During breastfeeding, it is recommended to avoid using this medication as it may be passed into breast milk. In cases of overdose, there is no specific antidote, so treatment should be symptomatic, monitoring liver function and muscle enzyme levels. Caution is needed as dizziness may occur when driving or operating machinery.

Side effects

Dyspepsia, pruritus, immune thrombocytopenia, facial edema, herpes zoster, vulvar pruritus, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, ALT elevation, chest pain, muscle cramps, gout, erectile dysfunction, numbness, dysesthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.